Calendar GenSight Biologics S.A.

Equities

SIGHT

FR0013183985

Real-time Euronext Paris 07:39:02 2024-03-28 am EDT 5-day change 1st Jan Change
0.4075 EUR +2.90% Intraday chart for GenSight Biologics S.A. -7.07% -11.41%

Chart calendar GenSight Biologics S.A.

188f23c9ba07d2b22c206b872dd80.HIiGhpiOTM5ZtaKOeJiYQxfLyG33FRKB0LoRaU51Gf8.Tv738qm2OKgB8Mr9Scj_NWK_ry-5fUbKnYh4HScheshvzPzq1Ogqiy3vwQ~9ab03eb23b143063335d54351963d90a

Upcoming events on GenSight Biologics S.A.

2024-07-23 Q2 2024 Earnings Release (Projected)
2025-03-20 Q4 2024 Earnings Release (Projected)
2025-07-22 Q2 2025 Earnings Release (Projected)
2026-03-19 Q4 2025 Earnings Release (Projected)

Past events on GenSight Biologics S.A.

2024-03-22 01:00 pm Q4 2023 Earnings Release
2024-01-24 Q4 2023 Sales and Revenue Release
2023-10-26 12:00 pm Q3 2023 Sales and Revenue Release
2023-07-25 Q2 2023 Earnings Release
2023-06-20 Annual General Meeting
2023-04-26 11:30 am Association for Research in Vision and Ophthalmology Meeting - Alfredo A. Sadun
2023-04-24 05:15 pm Association for Research in Vision and Ophthalmology Meeting - Chiara La Morgia
2023-04-24 05:00 pm Association for Research in Vision and Ophthalmology Meeting - Patrick Yu-Wai-Man
2023-04-24 12:03 pm American Academy of Neurology Meeting - Valérie Biousse
2023-04-24 11:51 am American Academy of Neurology Meeting - Nancy J. Newman
2023-04-20 10:30 am Business Update Call
2023-04-19 Q1 2023 Sales and Revenue Release
2023-04-05 08:00 am Business Update Call
2023-03-24 02:30 am Q4 2022 Earnings Release
2023-03-14 06:30 pm North American Neuro-Ophthalmology Society Meeting - Poster No: 279
2023-03-14 06:00 pm North American Neuro Ophthalmology Society Meeting - Mark L. Moster
2023-03-14 06:00 pm North American Neuro Ophthalmology Society Meeting - Patrick Yu-Wai-Man
2023-03-14 06:00 pm North American Neuro Ophthalmology Society Meeting - Catherine Vignal
2023-03-14 06:00 pm North American Neuro Ophthalmology Society Meeting - Alfredo A. Sadun
2023-01-26 01:30 am FY 2022 Sales and Revenue Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million EUR
Released
Forecast
Spread
4,30
6,80
-36.76%
4,90
7,10
-30.99%
7,40
9,33
-20.71%
7,70
12,5
-38.24%
4,90
4,30
13.95%
3,00
2,20
36.36%
EBITDA
Million EUR
Released
Forecast
Spread
-32,7
-24,7
-32.15%
-29,3
-27,5
-6.42%
-24,0
-18,0
-33.27%
-27,2
-23,0
-18.51%
-26,8
-36,7
27.05%
0,00
-26,1
-
EBIT
Million EUR
Released
Forecast
Spread
-33,0
-24,9
-32.53%
-30,3
-27,7
-9.4%
-24,9
-18,4
-35.55%
-28,1
-22,1
-27.15%
-27,8
-37,6
26.06%
-29,7
-27,2
-9.19%
Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-33,5
-22,8
-47.05%
-30,7
-29,4
-4.45%
-34,0
-18,9
-79.73%
-28,6
-23,2
-23.61%
-27,6
-33,4
17.31%
0,00
0,00
-
Net income
Million EUR
Released
Forecast
Spread
-33,5
-24,2
-38.24%
-30,7
-27,7
-10.65%
-34,0
-18,9
-79.66%
-28,6
-23,4
-22.22%
-27,6
-36,7
24.69%
-26,2
-26,3
0.38%
EPS
EUR
Released
Forecast
Spread
-1,37
-0,98
-40.27%
-1,08
-0,96
-11.94%
-0,97
-0,53
-81.88%
-0,63
-0,50
-26%
-0,60
-0,80
25%
-0,54
-0,58
6.9%
Announcement Date24/04/1912/03/2010/03/2108/04/2224/03/2322/03/24

Quarterly results

Fiscal PeriodDecember 2019 S1
Net income
Million EUR
Released
Forecast
Spread
-17,3
-15,2
-13.82%
Announcement Date24/07/19

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise